Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine

References

• Altar CA, Hornberger J, Shewade A, et al. (2013). Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy. Int Rev Psychiatry 25:509–33
   PubMed Web of Science ®Google Scholar
• Budd K, Langford R. (1999). Tramadol revisited. Br J Anaesth 82:493–5
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Adams EH, Geller A, et al. (1999). A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 57:7–22
   PubMed Web of Science ®Google Scholar
• de Jong FA, Marsh S, Mathijssen RH, et al. (2004). ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition. Clin Cancer Res 10:5889–94
   PubMed Web of Science ®Google Scholar
• Dominguez-Ramirez AM, Cortes-Arroyo AR, Y de la Peña MH, et al. (2010). Effect of metamizol on morphine pharmacokinetics and pharmacodynamics after acute and subchronic administration in arthritic rats. Eur J Pharmacol 645:94–101
   PubMedGoogle Scholar
• Dutheil F, Dauchy S, Diry M, et al. (2009). Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos 37:1528–38
   PubMed Web of Science ®Google Scholar
• Dutheil F, Jacob A, Dauchy S, et al. (2010). ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders. Expert Opin Drug Metab Toxicol 6:1161–74
   PubMed Web of Science ®Google Scholar
• Ferguson CS, Tyndale RF. (2011). Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 32:708–14
   PubMed Web of Science ®Google Scholar
• Ghosheh O, Dwoskin LP, Li WK, et al. (1999). Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2′-(14)C]nicotine. Drug Metab Dispos 27:1448–55
   PubMedGoogle Scholar
• Gonzalez FJ, Yu AM. (2006). Cytochrome P450 and xenobiotic receptor humanized mice. Annu Rev Pharmacol Toxicol 46:41–64
   PubMed Web of Science ®Google Scholar
• Grond S, Sablotzki A. (2004). Clinical pharmacology of tramadol. Clin Pharmacokinet 43:879–923
   PubMed Web of Science ®Google Scholar
• Hedlund E, Wyss A, Kainu T, et al. (1996). Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene. Mol Pharmacol 50:342–50
   PubMed Web of Science ®Google Scholar
• Hwa Jung B, Chul Chung B, Chung SJ, et al. (2001). Different pharmacokinetics of nicotine following intravenous administration of nicotine base and nicotine hydrogen tartarate in rats. J Control Release 77:183–90
   PubMedGoogle Scholar
• Lavasani H, Sheikholeslami B, Ardakani YH, et al. (2013). Study of the pharmacokinetic changes of Tramadol in diabetic rats. Daru 21:17
   PubMedGoogle Scholar
• Legette L, Ma L, Reed RL, et al. (2012). Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration. Mol Nutr Food Res 56:466–74
   PubMed Web of Science ®Google Scholar
• Lewis DF. (1998). The CYP2 family: models, mutants and interactions. Xenobiotica 28:617–61
   PubMed Web of Science ®Google Scholar
• Liu HC, Hu YQ, Liu JF, et al. (2001). [Transportation of the enantiomers of trans tramadol and O-demethyltramadol across blood–brain barrier]. Yao Xue Xue Bao 36:644–7
   PubMedGoogle Scholar
• Liu HC, Jin SM, Wang YL. (2003). Gender-related differences in pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in rats. Acta Pharmacol Sin 24:1265–9
   PubMedGoogle Scholar
• Loram LC, Mitchell D, Skosana M, et al. (2007). Tramadol is more effective than morphine and amitriptyline against ischaemic pain but not thermal pain in rats. Pharmacol Res 56:80–5
   PubMedGoogle Scholar
• Mahdy T, El-Shihi TH, Emara MM, et al. (2012). Development and validation of a new GC–MS method for the detection of tramadol, O-desmethyltramadol, 6-acetylmorphine and morphine in blood, brain, liver and kidney of Wistar rats treated with the combination of heroin and tramadol. J Anal Toxicol 36:548–59
   PubMed Web of Science ®Google Scholar
• Mann A, Miksys S, Lee A, et al. (2008). Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology 55:1147–55
   PubMed Web of Science ®Google Scholar
• Masubuchi Y, Hosokawa S, Horie T, et al. (1994a). Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Drug Metab Dispos 22:909–15
   PubMed Web of Science ®Google Scholar
• Masubuchi Y, Narimatsu S, Hosokawa S, et al. (1994b). Role of the CYP2D subfamily in metabolism-dependent covalent binding of propranolol to liver microsomal protein in rats. Biochem Pharmacol 48:1891–8
   PubMed Web of Science ®Google Scholar
• Meyer RP, Gehlhaus M, Knoth R, et al. (2007). Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab 8:297–306
   PubMed Web of Science ®Google Scholar
• Miksys S, Rao Y, Hoffmann E, et al. (2002). Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem 82:1376–87
   PubMed Web of Science ®Google Scholar
• Miksys S, Tyndale RF. (2009). Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition. Neuropsychopharmacology 34:634–40
   PubMed Web of Science ®Google Scholar
• Miksys S, Tyndale RF. (2013). Cytochrome P450-mediated drug metabolism in the brain. J Psychiatry Neurosci 38:152–63
   PubMed Web of Science ®Google Scholar
• Nirogi R, Ajjala DR, Kandikere V, et al. (2013). LC-MS/MS method for the quantification of almotriptan in dialysates: application to rat brain and blood microdialysis study. J Pharm Biomed Anal 81–82:160–7
   PubMedGoogle Scholar
• Olesen J, Hougard K, Hertz M. (1978). Isoproterenol and propranolol: ability to cross the blood-brain barrier and effects on cerebral circulation in man. Stroke 9:344–9
   PubMedGoogle Scholar
• Parasrampuria R, Vuppugalla R, Elliott K, et al. (2007). Route-dependent stereoselective pharmacokinetics of tramadol and its active O-demethylated metabolite in rats. Chirality 19:190–6
   PubMedGoogle Scholar
• Paxinos G, Watson C. (2014). The rat brain in stereotaxic coordinates. San Diego: Elsevier Academic Press
   Google Scholar
• Rendic S. (2002). Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 34:83–448
   PubMed Web of Science ®Google Scholar
• Riddick DS, Lee C, Bhathena A, et al. (2004). Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab Dispos 32:367–75
   PubMed Web of Science ®Google Scholar
• Rivory LP, Haaz MC, Canal P, et al. (1997). Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials. Clin Cancer Res 3:1261–6
   PubMed Web of Science ®Google Scholar
• Rowland M, Tozer TN. (1989). Clinical pharmacokinetics: concepts and applications. Philadelphia, PA: Lea & Febiger
   Google Scholar
• Seliskar M, Rozman D. (2007). Mammalian cytochromes P450 – importance of tissue specificity. Biochim Biophys Acta 1770:458–66
   PubMed Web of Science ®Google Scholar
• Siegle I, Fritz P, Eckhardt K, et al. (2001). Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 11:237–45
   PubMedGoogle Scholar
• Tao Q, Stone DJ, Borenstein MR, et al. (2002). Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orally. J Clin Pharm Ther 27:99–106
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Dong G, et al. (2014). The endogenous substrates of brain CYP2D. Eur J Pharmacol 724:211–18
   PubMed Web of Science ®Google Scholar
• Warner M, Kohler C, Hansson T, et al. (1988). Regional distribution of cytochrome P-450 in the rat brain: spectral quantitation and contribution of P-450b,e, and P-450c,d. J Neurochem 50:1057–65
   PubMed Web of Science ®Google Scholar
• Yue J, Miksys S, Hoffmann E, et al. (2008). Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course. J Psychiatry Neurosci 33:54–63
   PubMed Web of Science ®Google Scholar
• Zahari Z, Ismail R. (2014). Influence of cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics. Drug Metab Pharmacokinet 29:29–43
   PubMedGoogle Scholar
• Zheng Q, Wang F, Li H, et al. (2012). Quantitative analysis of olanzapine in rat brain microdialysates by HPLC-MS/MS coupled with column-switching technique. J Chromatogr B Analyt Technol Biomed Life Sci 905:127–32
   PubMedGoogle Scholar
• Zhou K, Khokhar JY, Zhao B, et al. (2013). First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo. Biochem Pharmacol 85:1848–55
   PubMed Web of Science ®Google Scholar